Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding

Limited data exist in large, representative populations about whether the risk of thromboembolic events varies after receiving four-factor human prothrombin complex concentrate (4F-PCC) versus treatment with human plasma for urgent reversal of oral vitamin K antagonist therapy. We conducted a multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Alan S., Leong, Thomas K., Sung, Sue Hee, Wei, Rong, Harrison, Teresa N., Gupta, Nigel, Baker, Nicole, Goldstein, Brahm, Ataher, Quazi, Solomon, Matthew D., Reynolds, Kristi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553785/
https://www.ncbi.nlm.nih.gov/pubmed/35984591
http://dx.doi.org/10.1007/s11239-022-02695-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553785/
https://www.ncbi.nlm.nih.gov/pubmed/35984591
http://dx.doi.org/10.1007/s11239-022-02695-5

Ejemplares similares